Total Payments
$11,577
2024 Payments
$1,110
Companies
45
Transactions
464
Medicare Patients
6,293
Medicare Billing
$687,145
Payment Breakdown by Category
Food & Beverage$11,577 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,577 | 464 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CARDIVA MEDICAL, INC. | $2,321 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,678 | 97 | $0 (2024) |
| Boston Scientific Corporation | $1,410 | 31 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,006 | 16 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $696.06 | 40 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $642.23 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $581.16 | 33 | $0 (2024) |
| Novo Nordisk Inc | $524.49 | 38 | $0 (2024) |
| Amgen Inc. | $431.82 | 34 | $0 (2022) |
| Medtronic, Inc. | $262.56 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,110 | 31 | Inari Medical, Inc. ($187.97) |
| 2023 | $1,047 | 41 | Medtronic, Inc. ($216.19) |
| 2022 | $1,287 | 59 | Boston Scientific Corporation ($288.25) |
| 2021 | $1,487 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($337.66) |
| 2020 | $1,092 | 25 | CARDIVA MEDICAL, INC. ($438.46) |
| 2019 | $1,526 | 64 | CARDIVA MEDICAL, INC. ($355.29) |
| 2018 | $1,958 | 85 | CARDIVA MEDICAL, INC. ($372.10) |
| 2017 | $2,070 | 81 | CARDIVA MEDICAL, INC. ($395.84) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $132.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 10/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: General - Therapies_CRM | ||||||
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Stents | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $144.31 | General |
| 05/31/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: DEVICES | ||||||
| 05/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: General - Therapies_CRM | ||||||
| 05/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $123.96 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/24/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/05/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $49.86 | General |
| Category: DEVICES | ||||||
| 03/28/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Not Applicable | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Cardiovascular | ||||||
| 03/14/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $187.97 | General |
| Category: VTE | ||||||
| 03/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,348 | 1,981 | $406,098 | $153,701 |
| 2022 | 22 | 1,400 | 2,082 | $422,626 | $166,545 |
| 2021 | 25 | 1,751 | 3,796 | $509,277 | $196,967 |
| 2020 | 27 | 1,794 | 2,769 | $468,600 | $169,931 |
Total Patients
6,293
Total Services
10,628
Medicare Billing
$687,145
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 452 | 869 | $133,826 | $70,541 | 52.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 111 | 116 | $55,800 | $12,423 | 22.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 95 | 217 | $21,700 | $12,413 | 57.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 21 | 31 | $43,400 | $11,334 | 26.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 43 | 45 | $40,500 | $8,249 | 20.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 28 | 28 | $19,900 | $7,155 | 36.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 62 | $11,780 | $5,950 | 50.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 90 | 92 | $18,400 | $4,532 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 52 | $7,800 | $4,518 | 57.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 24 | 25 | $10,000 | $3,719 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $5,750 | $2,956 | 51.4% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 14 | $15,400 | $2,187 | 14.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 16 | 16 | $4,000 | $1,897 | 47.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 15 | $4,875 | $1,205 | 24.7% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 23 | 24 | $1,440 | $923.28 | 64.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 68 | 96 | $960.00 | $806.40 | 84.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 61 | 65 | $2,600 | $605.80 | 23.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 37 | $1,850 | $357.05 | 19.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 23 | 27 | $1,215 | $354.24 | 29.2% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 13 | 13 | $650.00 | $346.06 | 53.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 15 | 15 | $900.00 | $280.35 | 31.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 24 | $960.00 | $248.40 | 25.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 21 | 25 | $525.00 | $190.25 | 36.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 11 | 11 | $462.00 | $181.06 | 39.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 14 | $420.00 | $116.06 | 27.6% |
About Dr. Patrick Murphy, M.D
Dr. Patrick Murphy, M.D is a Cardiovascular Disease healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336130541.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Murphy, M.D has received a total of $11,577 in payments from pharmaceutical and medical device companies, with $1,110 received in 2024. These payments were reported across 464 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($11,577).
As a Medicare-enrolled provider, Murphy has provided services to 6,293 Medicare beneficiaries, totaling 10,628 services with total Medicare billing of $687,145. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Mobile, AL
- Active Since 11/04/2005
- Last Updated 05/15/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336130541
Products in Payments
- Vascular Closure Device (Device) $1,562
- ENTRESTO (Drug) $1,473
- Resolute (Device) $1,005
- XARELTO (Drug) $696.06
- ELIQUIS (Drug) $652.13
- JARDIANCE (Drug) $532.26
- SYNERGY (Device) $320.82
- Cardiva VASCADE MVP VVCS 6-12F (Device) $316.78
- CARDIVA VASCADE 6/7F VCS (Device) $273.45
- Corlanor (Drug) $257.27
- ONYX FRONTIER (Device) $231.18
- LEQVIO (Drug) $205.13
- FLOWTRIEVER CATHETER, S (Device) $187.97
- Ozempic (Drug) $172.96
- Saxenda (Drug) $158.83
- CARDIVA VASCADE MVP VVCS 6-12F (Device) $152.64
- Repatha (Biological) $151.83
- Impella (Device) $132.69
- GENERAL STENTS (Device) $124.36
- WATCHMAN FLX (Device) $123.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mobile
Dr. Dennis Thomas, M.d, M.D
Cardiovascular Disease — Payments: $885,159
Cardiovascular Disease $885,159
Dr. Kenneth Burnham, Md, MD
Cardiovascular Disease — Payments: $471,311
Cardiovascular Disease $471,311
Jordan Chaisson, M.d, M.D
Cardiovascular Disease — Payments: $96,312
Cardiovascular Disease $96,312
Luanda Grazette, M.d, M.D
Cardiovascular Disease — Payments: $39,914
Cardiovascular Disease $39,914
J O'dowd, Md, MD
Cardiovascular Disease — Payments: $27,472
Cardiovascular Disease $27,472
Chance Witt, Md, MD
Cardiovascular Disease — Payments: $18,119
Cardiovascular Disease $18,119